AP2 domain transcription factor ODP2 (ovule development protein 2) and methods of use
US-9340796-B2 · May 17, 2016 · US
US10125372B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10125372-B2 |
| Application number | US-201615097566-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 13, 2016 |
| Priority date | Feb 2, 2004 |
| Publication date | Nov 13, 2018 |
| Grant date | Nov 13, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and compositions for modulating plant development are provided. Nucleotide sequences and amino acid sequences encoding Ovule Development Protein 2 (ODP2) proteins are provided. The sequences can be used in a variety of methods including modulating development, developmental pathways, altering oil content in a plant, increasing transformation efficiencies, modulating stress tolerance, and modulating the regenerative capacity of a plant. Transformed plants, plant cells, tissues, and seed are also provided.
Opening claim text (preview).
What is claimed: 1. A method of promoting embryogenesis in a microspore and anther cultures, wherein said method comprises introducing into a plant an ODP2 nucleotide sequence that encodes an ODP2 polypeptide comprising an amino acid sequence selected from the group consisting of: (a) the amino acid sequence of SEQ ID NO: 2; (b) the amino acid sequence having at least 85% sequence identity to SEQ ID NO: 2, wherein said polypeptide renders a plant cell embryogenic. 2. The method of claim 1 , wherein said ODP2 nucleotide sequence is under the control of a tissue specific promoter that is active in a microspore. 3. The method of claim 1 , wherein said ODP2 nucleotide sequence is under the control of a promoter that is active during microspore development. 4. The method of claim 3 , wherein said promoter that is active during microspore development is the maize PG47 promoter or the zm-G13 promoter. 5. The method of claim 1 , wherein the ODP2 nucleotide sequence is under the control of an inducible promoter. 6. The method of claim 1 , wherein the ODP2 nucleotide sequence is under the control of a promoter that is an inducible pollen-specific promoter.
Male-specific, e.g. anther, tapetum, pollen · CPC title
from plants · CPC title
involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine · CPC title
for fertility modification, e.g. apomixis · CPC title
Female-specific, e.g. pistil, ovule · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.